Offer - Urjas Oil for just ₹ 1 X
Tsart Trio 6.25 Tablet is a commercial drug that is prescribed in the form of Tablet. The alternative uses of Tsart Trio 6.25 Tablet have also been explained below.
Medical history of the patient along with age and gender determines the dosage of Tsart Trio 6.25 Tablet. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. This information has been provided in detail in the dosage section.
Common side effects of Tsart Trio 6.25 Tablet include Back Pain, Loss of appetite, Gastric Irritation. Some other side effects of Tsart Trio 6.25 Tablet have been listed ahead. Such side effects of Tsart Trio 6.25 Tablet normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Tsart Trio 6.25 Tablet has a Mild effect for pregnant women and Mild effect on lactating mothers. Further, the section on Tsart Trio 6.25 Tablet related warnings talks about Tsart Trio 6.25 Tablet's effects on the liver, heart and kidney.
Tsart Trio 6.25 Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Low Blood Pressure (Hypotension), Angioedema, Hyperkalemia are examples of such conditions. Some other conditions that can be affected by Tsart Trio 6.25 Tablet are listed in the contraindications section below.
Drug reaction of Tsart Trio 6.25 Tablet with other medicines has been reported. Refer to the list below for further details.
In addition to these precautions, you may also note that Tsart Trio 6.25 Tablet is not safe while driving, and is is not addictive in nature.
Tsart Trio 6.25 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Tsart Trio 6.25 Tablet safe for pregnant women?
Tsart Trio has little to no side effects in pregnant women.
Is the use of Tsart Trio 6.25 Tablet safe during breastfeeding?
Tsart Trio may have very limited harmful effects for breastfeeding women.
What is the effect of Tsart Trio 6.25 Tablet on the Kidneys?
Tsart Trio rarely affects the kidneys.
What is the effect of Tsart Trio 6.25 Tablet on the Liver?
Tsart Trio is rarely harmful for the liver.
What is the effect of Tsart Trio 6.25 Tablet on the Heart?
Tsart Trio may have mild side effects on the heart. Most people will never see any effect on the heart.
If you are suffering from any of the following diseases, you should not take Tsart Trio 6.25 Tablet unless your doctor advises you to do so -
Is this Tsart Trio 6.25 Tablet habit forming or addictive?
Tsart Trio 6.25 Tablet is not addictive in nature.
Interaction between Food and Tsart Trio 6.25 Tablet
Tsart Trio 6.25 Tablet may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Tsart Trio 6.25 Tablet
Taking Tsart Trio 6.25 Tablet with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Thalitone ® (chlorthalidone)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 583-584
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448